Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders

Journal of Endocrinological Investigation

Volumn 31, Issue 10, 2008, Pages 861-865

  Nakamura, Hideki ^a   Usa, T ^a   Motomura, M ^a   Ichikawa, T ^a   Nakao, K ^a   Kawasaki, E ^b   Tanaka, M ^c   Ishikawa, K ^c   Eguchi, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c Sales Department   (Japan)

Author keywords

Connective tissue diseases; Myasthenia gravis; Primary biliary cirrhosis; Thyroid disease; Type 1 diabetes

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; MUSCLE ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; RADIOIMMUNOASSAY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 58649101411     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346432     Document Type: Article

References (32)

1. Ballotti S, Chiarelli F, de Martino M. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part I. Horm Res 2006, 66: 132-41.
2. Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity 2005, 38: 303-17.
3. Scofield RH. Autoimmune thyroid disease in systemic lupus erythematosus and Sjögren's syndrome. Clin Exp Rheumatol 1996, 14: 321-30.
4. Kawasaki E, Eguchi K. Genetics of fulminant type 1 diabetes. Ann N Y Acad Sci 2006, 1079: 24-30.
5. Sanders J, Evans M, Premawardhana LD, et al. Human monoclonal thyroid stimulating autoantibody. Lancet 2003, 362: 126-8.
6. Kamijo K, Ishikawa K, Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Enclocr J 2005, 52: 525-9.
7. Beever K, Bradbury J, Phillips D, et al. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989, 35: 1949-54.
8. The Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20: 1183-97.
9. Sera N, Kawakami A, Nakashima T, et al. Fas/FasL mediated apoptosis of thyrocytes in Graves'disease. Clin Exp Immunol 2001, 124: 197-207.
10. Ohta M, Obayashi H, Takahashi K, et al. Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus. Clin Chem 1996, 42: 1975-8.
11. Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay. Clin Chim Acta 2000, 291: 53-66.
12. Kawasaki E, Abiru N, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995, 8: 633-43.
13. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 2006, 49: 828-36.
14. Kawasaki E, Eguchi K. Current aspects on the clinical immunology and genetics of autoimmune diabetes in Japan. Diabetes Res Clin Pract 2007, 77: S104-9.
15. Kawasaki E, Yu L, Gianani R, et al. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab 1997, 82: 375-80.
16. Samuelsson U, Ludvigsson J, Sundkvist G. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (IC-SA) and C-pepticle in 1031 school children in a population with a high background incidence of IDDM. Diabetes Res Clin Pract. 1994, 26: 155-62.
17. Kawasaki E, Takino H, Yano M, et al. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid clecarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. J Autoimmun 1994, 7: 791-802.
18. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347: 151-6.
19. Kobayashi T, Tamemoto K, Nakanishi K, et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993, 16: 780-8.
20. Kawasaki E, Takino H, Yano M, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994, 43: 80-6.
21. Goswami R, Marwaha RK, Goswami D, et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroiclism in comparison to type 1 diabetes and premature ovarian failure. J Clin Endocrinol Metab 2006, 91: 4256-9.
22. Prázn-acy M, Skrha J, Límanová Z, et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol Res 2005, 54: 41-8.
23. Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol 2002, 35: 345-9.
24. Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004, 99: 1510-6.
25. MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 1997, 41: 423-31.
26. Shiraishi H, Motomura M, Yoshimura T, et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005, 57: 289-93.
27. Marinó M, Ricciardi R, Pinchera A, et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Enclocrinol Metab 1997, 82: 438-43.
28. Kiessling WR, Pflughaupt KW, Ricker K, Haubitz I, Mertens HG. Thyroid function and circulating antithyroid antibodies in myasthenia gravis. Neurology 1981, 31: 771-4.
29. Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002, 61: 70-2.
30. Magaro M, Zoli A, Altomonte L, et al. The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Rheumatol 1992, 10: 67-70.
31. Kausman D, Isenberg DA. Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol 1995, 34: 361-4.
32. Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome. Transl Res 2006, 148: 281-8.